Skip to main content
. 2015 Aug 13;26(5):2287–2318. doi: 10.1177/0962280215597260

Table 4.

Predictions obtained from all models for all studies in the ‘Sormani data’.

Disability progression rate ratio, mean (95% CrI)
Paty (1) Paty (2) Miligan Johnson Jacobs/Simon
Observed 1.00 (0.67, 1.49) 0.71 (0.45, 1.12) 1.14 (0.26, 5.03) 0.88 (0.57, 1.35) 0.63 (0.38, 1.05)
Meta-regression (FE) 0.99 (0.66, 1.48) 0.84 (0.53, 1.33) 0.93 (0.21, 4.11) 0.87 (0.56, 1.35) 0.85 (0.51, 1.42)
Meta-regression (RE) 0.99 (0.64, 1.53) 0.84 (0.52, 1.35) 0.92 (0.21, 4.13) 0.87 (0.54, 1.38) 0.85 (0.50, 1.45)
Daniels & Hughes 0.99 (0.63, 1.54) 0.84 (0.51, 1.37) 0.93 (0.20, 4.31) 0.87 (0.54, 1.41) 0.85 (0.50, 1.46)
BRMA (Wishart) 1.00 (0.47, 2.13) 0.81 (0.39, 1.68) 0.83 (0.16, 4.29) 0.81 (0.36, 1.82) 0.82 (0.36, 1.87)
BRMA (PNF) 0.97 (0.60, 1.57) 0.83 (0.49, 1.40) 0.86 (0.19, 3.95) 0.86 (0.52, 1.42) 0.83 (0.47, 1.48)

Fazekas Millefiorini Achiron Li (1) Li (2)
Observed 0.70 (0.36, 1.35) 0.19 (0.05, 0.79) 0.82 (0.19, 3.50) 0.81 (0.61, 1.08) 0.73 (0.54, 0.99)
Meta-regression (FE) 0.66 (0.34, 1.29) 0.61 (0.14, 2.55) 0.63 (0.15, 2.69) 0.87 (0.65, 1.17) 0.86 (0.63, 1.17)
Meta-regression (RE) 0.65 (0.33, 1.30) 0.60 (0.14, 2.53) 0.62 (0.14, 2.67) 0.87 (0.62, 1.21) 0.85 (0.60, 1.20)
Daniels & Hughes 0.65 (0.32, 1.32) 0.60 (0.14, 2.60) 0.62 (0.14, 2.73) 0.87 (0.62, 1.22) 0.86 (0.60, 1.23)
BRMA (Wishart) 0.70 (0.28, 1.76) 0.65 (0.14, 3.16) 0.64 (0.13, 3.16) 0.85 (0.43, 1.68) 0.84 (0.39, 1.79)
BRMA (PNF) 0.67 (0.33, 1.38) 0.65 (0.15, 2.81) 0.67 (0.15, 2.97) 0.86 (0.58, 1.25) 0.84 (0.57, 1.24)

Clanet Durelli Baumhackl Polman Rudick
Observed 1.00 (0.83, 1.20) 0.43 (0.24, 0.78) 1.08 (0.74, 1.57) 0.59 (0.46, 0.75) 0.79 (0.65, 0.96)
Meta-regression (FE) 1.08 (0.87, 1.34) 0.88 (0.48, 1.59)* 0.94 (0.64, 1.39) 0.58 (0.43, 0.78) 0.66 (0.53, 0.83)
Meta-regression (RE) 1.08 (0.82, 1.43) 0.87 (0.48, 1.61)* 0.94 (0.62, 1.43) 0.57 (0.40, 0.80) 0.66 (0.51, 0.86)
Daniels & Hughes 1.10 (0.84, 1.44) 0.88 (0.47, 1.64)* 0.94 (0.60, 1.46) 0.57 (0.39, 0.82) 0.66 (0.51, 0.87)
BRMA (Wishart) 1.04 (0.60, 1.79) 0.84 (0.35, 2.01) 0.91 (0.42, 1.95) 0.56 (0.27, 1.15) 0.69 (0.30, 1.59)
BRMA (PNF) 1.07 (0.77, 1.48) 0.85 (0.45, 1.61)* 0.91 (0.58, 1.44) 0.57 (0.37, 0.88) 0.67 (0.48, 0.94)

Coles (1) Coles (2) Mikol Comi (1) Comi (2)
Observed 0.35 (0.16, 0.74) 0.38 (0.19, 0.77) 1.34 (0.88, 2.06) 0.69 (0.52, 0.93) 0.73 (0.55, 0.97)
Meta-regression (FE) 0.58 (0.27, 1.26) 0.49 (0.24, 1.01) 1.03 (0.66, 1.60) 0.66 (0.48, 0.91) 0.69 (0.51, 0.93)
Meta-regression (RE) 0.58 (0.26, 1.26) 0.48 (0.23, 1.01) 1.03 (0.65, 1.63) 0.65 (0.46, 0.93) 0.68 (0.48, 0.95)
Daniels & Hughes 0.58 (0.26, 1.30) 0.49 (0.23, 1.05) 1.04 (0.64, 1.69) 0.64(0.42, 0.99) 0.67 (0.45, 1.00)
BRMA (Wishart) 0.64 (0.23, 1.75) 0.60 (0.22, 1.58) 0.92 (0.43, 1.97) 0.59 (0.28, 1.22) 0.71 (0.30, 1.67)
BRMA (PNF) 0.63 (0.28, 1.41) 0.55 (0.25, 1.21) 0.97 (0.59, 1.59) 0.68 (0.45, 1.04) 0.69 (0.46, 1.05)

Havrdova (1) Havrdova (2) Sorensen O'Connor (1) O'Connor (2)
Observed 1.23 (0.58, 2.62) 1.04 (0.48, 2.27) 0.64 (0.32, 1.28) 1.05 (0.84, 1.31) 1.10 (0.88, 1.37)
Meta-regression (FE) 0.96 (0.45, 2.05) 0.86 (0.39, 1.88) 0.63 (0.31, 1.27) 1.06 (0.83, 1.37) 1.00 (0.78, 1.27)
Meta-regression (RE) 0.96 (0.44, 2.07) 0.86 (0.39, 1.89) 0.62 (0.30, 1.27) 1.07 (0.78, 1.45) 1.00 (0.75, 1.34)
Daniels & Hughes 0.96 (0.43, 2.10) 0.86 (0.38, 1.92) 0.62 (0.29, 1.31) 1.06 (0.79, 1.42) 0.99 (0.75, 1.32)
BRMA (Wishart) 0.93 (0.34, 2.51) 0.81 (0.30, 2.19) 0.63 (0.24, 1.65) 0.84 (0.43, 1.65) 0.95 (0.48, 1.87)
BRMA (PNF) 0.93 (0.42, 2.07) 0.84 (0.37, 1.92) 0.66 (0.31, 1.42) 1.01 (0.70, 1.47) 0.98 (0.68, 1.39)